Clinical Trial

Therapeutic Effect of Surgical Debulking of Metastatic Lymph Nodes in Cervical Cancer Stage IIICr

Recruiting
View on ClinicalTrials.gov →
Summary
This study is a prospective, multicenter and randomized clinical trial (DEBULK trial) to determine the therapeutic effect of surgical debulking of bulky or multiple lymph nodes before concurrent chemoradiation therapy (CCRT) in cervical cancer stage IIICr.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-06-13; most recent amendment 2025-04-05.
Status change: Not Yet Recruiting → Recruiting 2023-02-07
Trial Details
NCT Number NCT05421650
Lead Sponsor CHA University
Collaborators: Korean Gynecologic Oncology Group
Conditions Cervical Cancer
Enrollment 240 participants
Start Date 2022-08-01
Primary Completion 2030-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-09